Going beyond the median: Estimating survival times for patients with hormone receptor positive, metastatic breast cancer commencing endocrine therapy

被引：0
|
作者：
Parsonson, Andrew O.
Sarkar, Sunit
Brown, Lauren
Kiely, Belinda
Vasista, Anuradha
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 05期
关键词：
D O I：
10.1158/1538-7445.SABCS22-P3-01-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3-01-10
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Endocrine Therapy for Hormone Receptor Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline Summary
    Rugo, Hope S.
    Rumble, R. Bryan
    Burstein, Harold J.
    JOURNAL OF ONCOLOGY PRACTICE, 2016, 12 (06) : 583 - U246
  • [22] Endocrine Therapy for Hormone Receptor-Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline
    Rugo, Hope S.
    Rumble, R. Bryan
    Macrae, Erin
    Barton, Debra L.
    Connolly, Hannah Klein
    Dickler, Maura N.
    Fallowfield, Lesley
    Fowble, Barbara
    Ingle, James N.
    Jahanzeb, Mohammad
    Johnston, Stephen R. D.
    Korde, Larissa A.
    Khatcheressian, James L.
    Mehta, Rita S.
    Muss, Hyman B.
    Burstein, Harold J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (25) : 3069 - +
  • [23] Association of Endocrine Therapy with Survival for Patients with Small, Hormone Receptor-Positive, HER2-Negative, Breast Cancer
    Ma, S. J.
    Oladeru, O. T.
    Sood, A. J.
    Mikucki, M.
    Farrugia, M. K.
    Singh, A. K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E74 - E74
  • [24] EXTENDED ADJUVANT ENDOCRINE THERAPY IN HORMONE-RECEPTOR POSITIVE BREAST CANCER
    Goss, P. E.
    Badovinac-Crnjevic, T.
    Fan, L.
    BREAST, 2013, 22 : S18 - S18
  • [25] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Sharvina Ziyeh
    Lauren Wong
    Reva K. Basho
    Current Oncology Reports, 2023, 25 : 689 - 698
  • [26] Extended adjuvant endocrine therapy in hormone-receptor positive breast cancer
    Strasser-Weippl, Kathrin
    Badovinac-Crnjevic, Tanja
    Fan, Lei
    Goss, Paul E.
    BREAST, 2013, 22 : S171 - S175
  • [27] The Optimal Duration of Endocrine Therapy in Hormone Receptor-Positive Breast Cancer
    Sledge, George W., Jr.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (06) : 383 - 404
  • [28] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Ziyeh, Sharvina
    Wong, Lauren
    Basho, Reva K.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 689 - 698
  • [29] Prognosis of hormone receptor positive recurrent breast cancer during endocrine therapy
    Akiyoshi, S.
    Oikawa, M.
    Koi, Y.
    Koga, C.
    Nishimura, S.
    Nakamura, Y.
    Ishida, M.
    Ohno, S.
    BREAST, 2015, 24 : S84 - S84
  • [30] Survival Outcomes in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With Low or No ERBB2 Expression Treated With Targeted Therapies Plus Endocrine Therapy
    Mouabbi, Jason A.
    Raghavendra, Akshara Singareeka
    Bassett, Roland L., Jr.
    Hassan, Amy
    Tripathy, Debasish
    Layman, Rachel M.
    JAMA NETWORK OPEN, 2023, 6 (05) : E2313017
12345